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Abstract
Background: Methicillin-resistant Staphylococcus pseudintermedius (MRSP) has emerged globally in companion animals
in the last decade. In Europe, the multidrug-resistant sequence type (ST)71 is widespread, but recently other clones
have appeared. The objective of this study was to examine genotypic diversity and antimicrobial resistance of clinical
MRSP isolates obtained from dogs, including dogs sampled on multiple occasions, in Denmark over a six-year period.
For that purpose a total of 46 clinical MRSP isolates obtained from 36 dogs between 2009 and 2014 were subjected to
antimicrobial susceptibility testing, multilocus-sequence typing (MLST) and SCCmec typing.
Results: Twenty-three sequence types were identified with ST71, mostly associated with SCCmec II-III, as the most
common occurring in 13 dogs. Among the remaining 33 isolates, 19 belonged to clonal complex (CC)258 comprising
ST258-SCCmec IV and its single- and double-locus variants. These were susceptible to 4–7 of the 22 antibiotics tested,
whereas CC71 isolates were susceptible to only 2–5 antibiotics. Clone-specific differences were especially pronounced
for fluoroquinolones and aminoglycosides with most CC71 isolates being resistant and almost all CC258 isolates being
susceptible. Sixteen of the 19 CC258 isolates had oxacillin MICs of 0.5 g/L, whereas MICs for CC71 isolates were
consistently above 4 g/L. Four of five dogs representing multiple isolates had distinct STs on different sampling events.
Conclusions: The overall genotypic diversity of MRSP is high in Denmark indicating multiple acquisitions of SCCmec
into distinct clones, and mutational evolution, which appears to be particularly rapid for certain ancestral clones such
as ST258. ST71-SCCmec II-III is the most common MRSP lineage and is typically multidrug-resistant. CC258-SCCmec IV
isolates, which emerged in Denmark since 2012, display susceptibility to a wider range of antimicrobials. The isolation
of distinct STs in individual dogs over time suggests repeated exposure or short-term genetic evolution of MRSP clones
within patients.
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Background
Staphylococcus pseudintermedius is an opportunistic
pathogen in dogs causing mainly integumentary infec-
tions [1]. In the last decade, methicillin-resistant S.
pseudintermedius (MRSP) has emerged globally.
MRSP is resistant to all beta-lactams, and multidrug-
resistance occurs frequently, especially among multilocus
sequence type (ST)71 and ST68, which predominate in
dogs across Europe and North America, respectively [2].
Recently, other clones such as ST258 and closely related
variants have been detected with relatively high frequency
in Norway [3, 4] and the Netherlands [5], and sporadic-
ally in other EU countries [6–9]. Apart from often
being resistant to fewer antimicrobial classes, these
clones appear to be less virulent than ST71 as sug-
gested by a lower tendency to produce biofilm [3]
and less adherence to canine corneocytes [10]. The
aim of this study was to assess the genotypic diversity
and antimicrobial susceptibility of canine clinical
MRSP isolates in Denmark over a 5-year period, with
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emphasis on temporal shifts in the general dog
population and in individual dogs sampled on
multiple occasions.
Methods
A total of 46 clinical MRSP isolates obtained from integu-
mentary infections (n = 37), mucosal sites (n = 4) or other
sites (n = 5) were collected at the University of Copenhagen
veterinary diagnostic laboratory Sund Vet Diagnostik from
36 dogs between 2009 and 2014. All isolates were verified
as MRSP by nuc and mecA PCR [11, 12]. Isolates were
tested for antimicrobial susceptibility using Sensititre
COMPAN1F broth microdilution plates (Thermo Fisher
Scientific, Hvidovre, Denmark) according to the Clinical
Laboratory Standards Institute [13]. Separately for doxy-
cycline, susceptibility was tested by disk diffusion according
to the breakpoints established by Maaland et al. [14].
Isolates were also subjected to Staphylococcal Cassette
Chromosome (SCC) mec typing [11] and multilocus se-
quence typing (MLST) [15]. STs were compared to the
existing S. pseudintermedius database using the eBURST
V3 software [16]. We used an arbitrary definition of clonal
complexes (CCs) that included major group/subgroup
founders (with more than 3 single-locus links) from the
MLST database and respective single- and double locus
variants (SLVs and DLVs).
Results and discussion
A total of 23 STs were detected among the 36 dogs
(Table 1), including two STs (ST258 and ST273) occur-
ring repeatedly in individual dogs at different sampling
times (Table 2). This high overall genotypic diversity is
notable and resembles what was recently observed in
Norway and the Netherlands [4, 5]. With regards to
number of dogs infected, ST71 predominated and was
detected in 13 dogs, whereas the second most common
Table 1 Characteristics of the 46 MRSP isolates included in the study
Clonal Com-plex MLST type No. of isolates No. of dogs SCCmec type No. (type) of antibiotics susceptible toa
CC45 ST45 3 3 NTb 2-3 (AMI, CHL, GEN, RIF, SXT)
ST288c 1 1 V 3 (AMI, CHL, RIF)
CC68 ST271c 1 1 V 4 (AMI, CHL, GEN, RIF)
CC71 ST71 13 13 II-III (n = 11) NT (n = 2) 2–5 (AMI, CHL, DOX, GEN, RIF, SXT)
ST270c 1 1 II–III 3 (CHL, RIF, SXT)
ST272d 1 1 II–III 2 (CHL, RIF)
CC258 ST118d 1 1 IV 7 (AMI, CHL, ENR, GEN, MAR, RIF, SXT)
ST258 7 2 IV 4–6 (AMI, CHL, ENR, GEN, MAR, RIF)
ST261c 1 1 IV 5 (AMI, CHL, GEN, MAR, RIF)
ST265d 1 1 IV 4 (CHL, ENR, MAR, RIF)
ST267d 1 1 IV 6 (AMI, CHL, ENR, GEN, MAR, RIF)
ST273c 2 1 IV 6 (AMI, CHL, ENR, GEN, MAR, RIF)
ST277c 1 1 IV 6 (AMI, ENR, GEN, MAR, RIF)
ST290d 2 2 IV, NT 6 (AMI, CHL, ENR, GEN, MAR, RIF)
ST301d 1 1 IV 4 (CLI, ERY, MAR, RIF)
ST414d 1 1 IV 5 (AMI, CHL, GEN, RIF, SXT)
ST430d 1 1 IV 7 (AMI, CHL, ENR, GEN, MAR, RIF, SXT)
NAe ST431 1 1 V 7 (AMI, CHL, CLI, DOX, ERY, GEN, RIF)
ST268 1 1 IV 7 (AMI, CHL, ENR, GEN, MAR, RIF, SXT)
ST269 2 2 IV 6–7 (AMI, CHL, ENR, GEN, MAR, RIF, SXT)
ST284 1 1 V 3 (AMI, RIF, SXT)
ST286 1 1 IV 6 (AMI, CHL, ENR, GEN, MAR, RIF)
ST295 1 1 NT 7 (AMI, DOX, ENR, GEN, MAR, RIF, SXT)
AMI amikacin, CHL chloramphenicol, CLI clindamycin, DOX doxycycline, ENR enrofloxacin, ERY erythromycin, GEN gentamicin, MAR marbofloxacin, RIF rifampicin,
SXT sulphamethoxazole and trimethoprim
aOut of the 22 antibiotics in the COMPAN1F broth microdilution panel. Underlined antibiotics are those for which some isolates within an ST were susceptible and
others resistant
bNT, not typeable with the method of Kondo et al. [11]
cSLV of the founder of the clonal complex
dDLV of the founder of the clonal complex
eNA, not applicable as the STs are singletons
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type (ST45) occurred in 3 dogs (Table 1). The frequent
detection of ST71 was not surprising given its wide-
spread appearance, and the occurrence of two closely re-
lated variants (ST270 and ST272) corroborates a recent
Japanese study showing that the ST71 lineage is not as
clonal as previously believed [17]. ST45 is the predomin-
ant MRSP clone in distant countries such as Australia,
Thailand and Israel [18–20], but it is also relatively com-
mon in Europe. In fact, similar to our findings, it was
the second most frequent MRSP clone after ST71 in
both the Netherlands and in Finland [5, 21]. The eleven
STs belonging to CC258 were detected in 13 dogs
(Table 1). The presence of all these closely related vari-
ants of ST258 could indicate that this clone has existed
and evolved for a longer time in Denmark than ST71.
However, the vast majority (95 %) of ST258 isolates and
variants from this study were obtained after 2012. A
more plausible explanation may therefore be that the
ST258 clone has a higher evolutionary rate than ST71,
or that some unknown factor has favoured its recent dis-
semination. Interestingly, a partial and gradual replace-
ment of CC71 with CC258 MRSP isolates was also
noted in the Netherlands recently [5].
SCCmec typing confirmed the well-known association
between ST71 and the SCCmec II-III element [2], except
in two isolates where no SCC element could be identi-
fied (Table 1). SCCmec type IV was associated with 14
MLST types. Even though many of these types are
closely related within CC258, the occurrence also in dis-
tantly related types (ST268, ST269, and ST286) suggests
enhanced mobility or a low fitness cost of this element
as seen in methicillin-resistant Staphylococcus aureus
(MRSA) [22]. SCCmec was non-typeable in the three
ST45 isolates. This may reflect presence of the pseudo-
SCCmec element (ΨSCCmec57395) that was recently dis-
covered in this clone by Perreten et al. [18].
Antibiotic susceptibility testing revealed the
multidrug-resistant nature of MRSP with only limited
susceptibility to veterinary licensed antibiotics. This was
particularly pronounced for certain clones (Table 1), for
example ST71 with three isolates being susceptible only
to chloramphenicol and rifampicin. Isolates belonging to
CC258 were generally susceptible to more antibiotic
classes compared to CC71 isolates (Table 1), thus sup-
porting the findings by Kjellman et al. [4] and Duim et
al. [5]. One of the major differences was that all 15
CC71 isolates were resistant to fluoroquinolones com-
pared to only 1 of 19 CC258 isolates (Table 1). A similar
picture was observed for aminoglycosides, since 10 of 15
CC71 isolates and 2 of 19 CC258 isolates were gentami-
cin resistant. Interestingly, the opposite trend was evi-
dent for doxycycline, with only 8 of 15 CC71 isolates
and all 19 CC258 isolates displaying resistance. Rifampicin
resistance was rarely detected (1/46 isolates), thus illus-
trating the potential use of this drug in systemic therapy
against MRSP. However, rifampicin is registered for use in
humans only and should be used with caution given its
potential side effects such as hepatotoxicity. Furthermore,
it should not be used as monotherapy but in combination
with other antibiotics, since mutations conferring resist-
ance readily develop during rifampicin therapy [23]. A
closer look at the susceptibility data showed that 16 of the
19 CC258 isolates had oxacillin MICs of 0.5 g/L, whereas
MICs for CC71 isolates were consistently above 4 g/L.
This could have important implications, as commercial
agar plates used by some laboratories for selective isola-
tion of MRSP were originally designed for detection of
MRSA, which have a higher oxacillin breakpoint than
MRSP [13] and may not allow growth of strains with low-
level oxacillin resistance. In order to check this we
streaked all 46 isolates on Brilliance MRSA 2 agar plates
(Thermo Fisher Scientific) followed by overnight incuba-
tion at 37 °C. Only one CC258 isolate failed to grow on
this medium, whereas various levels of growth were de-
tected among remaining isolates, irrespective of their oxa-
cillin MIC (data not shown). This indicates that at least
this commercial medium has a high sensitivity for detec-
tion of MRSP, although growth may not always be as
pronounced as for MRSA.
Two of the five dogs representing multiple isolates had
genetically unrelated MRSP clones isolated on different
sampling occasions (Dogs B and D, Table 2). Two previous
longitudinal studies detected MRSP from carrier sites such
as the nose and perineum for several months following
MRSP infections in dogs [24, 25]. In these studies the
Table 2 MRSP clones over time in dogs that were MRSP positive
on at least two sampling occasions
Dog ID Date of isolation
(month/year)
MLST type Relatedness of clones
A 12/09 ST268 6 of 7 alleles in common (SLVs)
08/10 ST269
B 12/12 ST45 1 of 7 alleles in common
01/13 ST71
C 07/12 ST258 –
10/12 ST258
D 10/12 ST71 2 of 7 alleles in common
11/12 ST295
E 01/12 ST258 6 of 7 alleles in common (SLVs)
03/12 ST273
06/12 ST273
07/12 ST258
11/12 ST258
12/12 ST258
02/13 ST258
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same clone was always recovered over time in individual
dogs. This difference to our study is difficult to explain, al-
though we analysed clinical isolates and not isolates from
carrier sites. Dogs B and D may have been exposed to
MRSP on multiple occasions, either in their normal envir-
onment or, perhaps more likely, at the veterinary clinics
they visited during infection. In Dogs A and E (Table 2),
the MRSP isolates were closely related (SLVs), suggesting
that these dogs might have been infected by a single clone,
which later evolved within the host. In all these dogs (A,
B, D, and E), infection or colonization with multiple
MRSP clones at the same time is possible, since Paul et al.
[26] showed high heterogeneity amongst S. pseudinterme-
dius isolates originating from different body sites of the
same dog. Presence of multiple clones would have gone
unnoticed in this study and in many other veterinary
diagnostic laboratories, which usually select only one
colony representing each morphological type for
susceptibility testing.
Two cases of likely dog-dog transmission were observed
based on the epidemiological information we retrieved.
One case concerned the two ST71 isolates with an un-
known SCCmec. These isolates had the same susceptibility
profile and originated from two unrelated dogs attending
the same hospital with a 2-week interval, suggesting trans-
mission via the hospital environment. Another case com-
prised two dogs living in the same family. These dogs
visited a veterinary hospital two weeks apart with skin in-
fections caused by MRSP ST71 and ST270, respectively.
These STs are SLVs, and the isolates shared the same anti-
biotic susceptibility profile. In this case transmission be-
tween the dogs, either before or after short-term evolution
of ST71, is a likely scenario, although independent acquisi-
tion of these strains cannot be ruled out.
Conclusions
In conclusion, Danish clinical MRSP isolates are geno-
typically diverse indicating multiple acquisitions of
SCCmec by distinct genetic backgrounds and rapid
evolution of certain clones such as ST258. ST71-
SCCmec II-III is the most common MRSP clone but the
recent emergence of the less resistant ST258-SCCmec IV
and related variants, signals a shift in the MRSP clonal
population, which is similar to the gradual shift observed
in the Netherlands recently. Further studies are needed
to clarify lineage-specific virulence properties, and to
assess whether the recent emergence of ST258 and re-
lated types in Europe has potential impact on veterinary
care. Our results support previous evidence that MRSP
can be a nosocomial pathogen [27]. Veterinary practi-
tioners should therefore focus on hygiene measures and
promote prudent antibiotic use to prevent spread of
MRSP between patients.
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